GDET’s New Cannabis Business Can Take PPS From $0.01 To $0.05


 

New York, NY -- March 15, 2019 -- InvestorsHub NewsWire -- www.nextbigticker.com -- GDET (USOTC: GDET) (GD Entertainment & Technology dba “GDET”) has run from $0.005 to a high of over $0.02 on over 100 million shares of trading.  This is record volume for GDET and nearly a year since the PPS has seen north of $0.01.  Speculation that GDET would announce a new cannabis business drove the stock up and news of GDET actually launching a cannabis business saw the PPS retrace back into the $0.01 range.  Some speculative short selling probably contributed to the profit taking that resulted in the retrace.  The GDET PPS is now basing nicely in the $0.01 range and the company clearly has more news yet to release on its new cannabis business.  GDET management indicates product details on its new CBD line are coming soon.  Not to mention more news likely in the works on the company’s Bitcoin business.  $0.01 to $0.02 is a good accumulation range in anticipation of a run to $0.05 or higher in light of GDET’s 52-week high of $0.15.


With Canada legalizing recreational marijuana last year, and the U.S. recently legalizing hemp farming under the 2018 Farm Act, and state by state marijuana legalization continuing to grow, the market is hot for new cannabis plays.  Take a look at some of the hot cannabis sector performers to get an idea of where GDET could go – for instance, Cannabis Science (USOTC: CBIS), Medical Marijuana (USOTC: MJNA), and Pot Networks (USOTC: POTN).

DISCLAIMER: NextBigTicker.com (NBT)is a third party publisher and news dissemination service provider. NBT is NOT affiliated in any manner with any company mentioned herein. NBT is news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. NBT's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release or opinion of the writer. NBT is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. NBT has not been compensated for this release and HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

Disclaimer/Safe Harbor:

This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur.

Source: www.nextbigticker.com

Medical Marijuana (PK) (USOTC:MJNA)
Historical Stock Chart
From Oct 2024 to Nov 2024

Medical Marijuana (PK) (USOTC:MJNA)
Historical Stock Chart
From Nov 2023 to Nov 2024